Achieving adequate preoperative sedation in autism remains one of the most formidable challenges in pediatric anesthesiology. Children and adolescents with severe autism spectrum disorder frequently experience intense sensory overload, profound communication barriers, and extreme distress during clinical encounters. Consequently, conventional non-invasive techniques often fail to facilitate peaceful induction. When standard oral medications trigger severe agitation and intramuscular injections cause trauma, clinicians must explore innovative salvage pathways. Delivering sedatives through an indwelling cecostomy tube offers an intriguing, novel perspective for managing uncooperative surgical candidates.

The Challenge of Preoperative Sedation in Autism

Sensory processing abnormalities and severe situational anxiety frequently impair perioperative cooperation in neurodivergent pediatric patients. Consequently, unfamiliar surgical environments, loud monitor alarms, and strange personnel rapidly provoke defensive aggression or physical resistance. In these fraught scenarios, healthcare teams typically attempt oral preanesthetic medication. However, forced oral administration often proves impossible because patients may spit out suspensions, bite medication cups, or experience traumatic decompensation. Furthermore, physical restraint to administer intramuscular injections creates significant psychological trauma for both the child and their caregivers. Repetitive traumatic experiences also exacerbate procedural aversion during future hospital visits. Because conventional delivery methods frequently precipitate aggressive confrontations, clinicians must meticulously plan every phase of the induction sequence. An ideal preanesthetic strategy must minimize perceived threats while reliably delivering predictable drug concentrations. As a result, multidisciplinary teams increasingly recognize the necessity of tailoring drug delivery to the patient's existing anatomical conduits and unique behavioral profile.

Clinical Presentation: The Dilemma of Failed Conventional Routes

A recent case report documented a 40-kg, 13-year-old adolescent boy diagnosed with severe autism spectrum disorder who presented for comprehensive dental rehabilitation. The patient suffered from longstanding chronic constipation, which clinicians had previously managed through surgical placement of a percutaneous cecostomy tube. Because of severe sensory sensitivity and cognitive impairment, outpatient dental care without general anesthesia was impossible. During prior medical encounters, standard premedication protocols had failed entirely. Specifically, attempts at administering oral sedatives generated extreme combative behavior, while intended intramuscular administration triggered severe physical aggression. The patient's physical strength created a substantial risk of physical injury to staff. Therefore, the anesthesia team faced a critical dilemma regarding how to induce sedation safely without resorting to dangerous physical restraint. Restraining a muscular adolescent elevates catecholamines, impairs airway control, and heightens the likelihood of emergence delirium. In this critical context, the care team evaluated the patient's indwelling cecostomy button as an unexploited enteral route for delivering sedative pharmacotherapy.

Pharmacological Administration via the Cecostomy Conduit

To achieve smooth induction, anesthesiologists administered a carefully selected combination of midazolam and ketamine directly through the patient's indwelling cecostomy button. Specifically, they introduced midazolam at 10 mg (0.25 mg/kg) and ketamine at 200 mg (5 mg/kg) into the cecal lumen, followed by a small saline flush. This non-threatening intervention completely bypassed the sensory triggers that usually accompany oral administration or needle injections. As a result, the adolescent experienced zero anticipatory fear and remained calm in his preoperative space. Within twenty minutes, the patient demonstrated profound sedation, permitting peaceful transport to the operating suite. Consequently, the anesthesia team secured peripheral intravenous access and executed smooth inhalational induction without physical resistance. The multidisciplinary dental rehabilitation then proceeded uneventfully under general endotracheal anesthesia. Throughout recovery, the patient maintained hemodynamic stability, demonstrated intact airway reflexes, and exhibited no paradoxical agitation. Thus, this inventive technique transformed what could have been a traumatic clinical event into an orderly, humane induction.

Physiological Mechanisms of Cecal Drug Absorption

Administering sedatives into the cecum presents unique pharmacokinetic considerations that clinicians must evaluate. The cecum and ascending colon possess extensive mucosal vascularization; however, their total absorptive surface area is markedly lower than that of the small intestine. Furthermore, medications introduced into the proximal large bowel undergo systemic uptake primarily through colonic mesenteric veins, which drain directly into the hepatic portal circulation. Consequently, drugs absorbed via this route remain subject to significant first-pass hepatic metabolism, resembling oral ingestion rather than low rectal administration. Rectal delivery partially bypasses hepatic clearance via inferior and middle rectal venous channels; however, cecal administration lacks this anatomical bypass. Despite substantial hepatic clearance, the lipophilic nature of ketamine and midazolam facilitates rapid trans-epithelial passive diffusion across colonic enterocytes. Moreover, because the patient routinely received antegrade flushes, the mucosal surface remained relatively clean, enhancing drug contact. Therefore, the synergistic interaction between midazolam and ketamine achieved effective therapeutic plasma levels despite lower systemic bioavailability.

Safety Considerations and Practical Clinical Nuances

Although cecostomy administration succeeded remarkably in this individual case, anesthesiologists must recognize several clinical uncertainties before adopting this route. First, colonic drug absorption exhibits variable bioavailability depending on local luminal contents, stool impaction, and mucosal transit time. Retained fecal matter can sequester active pharmaceutical compounds, leading to delayed systemic uptake or unpredictable sedation depths. Second, clinicians must formulate precise dosing strategies, as standard mucosal doses may yield variable bioavailability. If sedative absorption is unexpectedly delayed, premature administration of supplementary sedatives could provoke sudden cumulative respiratory depression. Therefore, continuous monitoring of respiratory excursion, oxygen saturation, and cardiac rhythm remains paramount throughout the sedation period. In addition, healthcare providers must inspect the cecostomy site for mechanical leakage before instilling medications. Clinicians must also establish clear emergency airway rescue plans prior to drug administration. Ultimately, pediatric anesthesiologists should reserve this non-standard access for carefully selected patients possessing preexisting enteral access and extreme resistance to conventional sedative pathways.

Frequently Asked Questions

How does cecal drug administration compare to rectal delivery for sedation?

Cecal drug administration differs significantly from rectal delivery because medications absorbed in the cecum enter the portal venous system. Consequently, they undergo complete first-pass hepatic metabolism, which reduces overall systemic bioavailability. In contrast, rectal administration partially bypasses hepatic clearance via the middle and inferior rectal veins. Therefore, cecal delivery generally requires higher relative dosing to achieve comparable sedative plasma concentrations within an acceptable clinical timeframe.

Why are midazolam and ketamine frequently combined for uncooperative patients?

Clinicians combine midazolam and ketamine because they provide complementary neurochemical actions that maximize sedation while preserving hemodynamic stability. Midazolam enhances gamma-aminobutyric acid neurotransmission to produce anxiolysis, muscle relaxation, and anterograde amnesia. Meanwhile, ketamine antagonizes N-methyl-D-aspartate receptors to induce effective analgesia and dissociative sedation without depressing spontaneous respiration. Together, this synergistic combination minimizes individual drug dosages, accelerates onset, and reduces cardiovascular or respiratory adverse events during challenging inductions.

What clinical risks must teams anticipate when using non-standard enteral sedation?

When employing non-standard enteral sedation, clinical teams must anticipate erratic drug absorption, delayed peak onset, and potential stomal irritation. If residual fecal contents impede intestinal absorption, systemic drug delivery may stall, tempting clinicians to administer premature re-dosing. Consequently, unexpected delayed absorption can precipitate cumulative respiratory depression or airway compromise. Therefore, practitioners must maintain continuous cardiopulmonary monitoring, verify stoma patency beforehand, and keep immediate airway rescue equipment accessible at all times.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Drillings IM et al. Preoperative Sedation via Cecostomy Tube in an Autistic Adolescent: A Case Report. A A Pract. 2026 Oct 01. doi: 10.1213/XAA.0000000000002313. PMID: 42874046.


2. Brown J, et al. Procedural sedation in children with autism spectrum disorders in the emergency department. Am J Emerg Med. 2019;37(8):1414-1418.


3. Swartz J, et al. Perioperative care of the pediatric patient with autism spectrum disorder. Anesth Analg. 2020;130(2):475-481.


4. Darlong V, Shende D, Subramanian MS, Sunder R, Naik A. Oral ketamine or midazolam or low dose combination for premedication in children. Anaesth Intensive Care. 2004;32(2):246-249.